Podcasts about global r

Dr. Tania Small joined Bristol Myers Squibb as Senior Vice President, Global Medical Affairs in January 2024. Tania brings a strong scientific track record leading Medical Affairs teams in driving innovation that improves the experience and supports better outcomes of people living with cancer and rare diseases. She has successfully built and led global and regional medical organizations in Drug Development and Medical Affairs, advancing access to Oncology, Rare Disease and Hematology patients globally.Tania is a board-certified pediatric hematology, oncology, and bone marrow transplant specialist with deep experience in clinical research and drug development. She has extensive research experience in oncology, hematology, gene therapy and stem cell transplantation, receiving NIH grants for her translational research in gene therapy and regenerative medicine.Most recently, Tania served as Head of Global Medical Oncology and was the sponsor of the Global R&D Inclusion Diversity Council at GSK. Prior to GSK, Tania worked for IPSEN as Vice President, Head of Oncology and Rare Disease Global Drug Development.She is energized by revolutionizing the experience and outcomes for people with cancer, and has worked closely with the US FDA, Congress, and the American Society of Clinical Oncology (ASCO) to improve the diversity of enrollment in oncology clinical trials and elderly programs."I'm passionate about partnering to create programs that treat the person - not just the disease. Producing groundbreaking solutions that can change the trajectory of serious diseases and help write the next chapter of patient-driven science is what motivates me every day."Tania received her medical degree from Albert Einstein College of Medicine. She has a long-standing affiliation with the Morgan Stanley Children's Hospital of New York Presbyterian/Columbia University where she completed her residency and hematology/oncology fellowship with an academic research appointment in heme and bone marrow transplant.Currently, Tania serves on the ASCO Membership Advisory Committee and is a Board Member of Accreditation Council for Medical Affairs (ACMA).

Last night, we linked up with @flolikethis at an exclusive media dinner at RAIN HTX for a deep dive into their journey. From viral fame to industry respect, FLO shares their story, creative process, and what's next. Tap in for an unfiltered convo with the UK's rising R&B queens.

Send us a textDr. Jackie Kunzler, Ph.D. is Senior Vice President and Global Head of Research and Development (R&D), and member of the Executive Management Committee, of Terumo Blood and Cell Technologies ( https://www.terumobct.com/ ), where she focuses on innovation and development leading the way for unlocking the potential of blood and cell collections in varied sectors, including blood banking, plasma-based therapies and cell and gene therapies.Dr. Kunzler joined Terumo from Baxter Healthcare where she held successive leadership roles in their business, including as Baxter Healthcare's Senior Vice President for Quality and Regulatory and Head of Global Life Sciences.Dr. Kunzler holds a Ph.D. in Cell Biology/Neuroscience from the University of Illinois, Chicago. She earned a Master of Science in Toxicology from the University of Florida, Bachelor's degrees in Biology and Medical Technology (Laboratory Medicine) from University of Iowa and an MBA in Healthcare Administration from Benedictine University.#Terumo #JackieKunzler #Blood #SickleCell #Alzheimers #Dementia #Biotherapies #Immunology #TherapeuticApheresis #AutoimmuneDiseases  #BloodDisorders  #BloodBanking #TransfusionMedicine #RegenerativeMedicine #TherapeuticPlasmaExchange #ConvalescentPlasma #ExtracorporealPhotopheresis #Parabiosis #Longevity #Aging #HospiceCare #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

Nella puntata di oggi parleremo packaging e del suo utilizzo nel mondo beauty.  Lo faremo con Maurizio Ficcadenti, Global R&D Manager di Baralan, azienda che da oltre 60 anni è parte della filiera dell'industria del packaging cosmetico primario.  Una nuova puntata ogni martedì alle 7.   Se vuoi contattarci scrivici su Linkedin: ci trovi come Trudy Berger e Arianna Alessio oppure ci trovi all'email ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠lusso360.podcast@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 

⬇️⬇️⬇️ En el episodio de hoy de "Las Claves de la Mañana": exploramos los últimos acontecimientos en Estados Unidos, donde Donald Trump se perfila como el próximo presidente tras una jornada electoral clave. Además, destacamos el histórico récord de México en el comercio exterior con EE. UU., y las tensiones que surgen tras las acciones de la Suprema Corte sobre la reforma judicial en México. También analizamos la alerta de la ONU sobre la independencia judicial en nuestro país y las preocupantes implicaciones de la destitución masiva de jueces. Además, Claudia Sheinbaum responde a las amenazas arancelarias de Trump, y en Puebla, Armenta y Harfuch se reúnen para discutir seguridad. No te pierdas los análisis y más noticias clave de esta jornada. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Ya puedes encontrar aquí el link a todas mis redes sociales.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Send us a textDr. Mehmood Khan, MD is the Chief Executive Officer of Hevolution Foundation ( https://www.hevolution.com/ ), a first of its kind non-profit organization that funds research through grants and provides investments in biotech to incentivize healthspan science across disciplines and borders for the benefit of all. Established by a Saudi Royal Decree, with its headquarters in Riyadh, with additional international hubs to support the expansion and execute the global mission, it's vision is to expand healthy human lifespan for the benefit of all humanity.  Hevolution Foundation aims to be positioned as a global leader, catalyst, partner, and convener, to increase the number of scientists entering the field, to increase the investable opportunities in the field of aging, and to help shape the regulatory and government environment.Dr. Khan also currently serves as the Executive Chairman of Life Biosciences Inc. where he joined the company in April 2019 as the Chief Executive Officer and Board Member. Life Biosciences was founded to advance scientific research and develop innovative new therapies to improve and extend healthy lives for everyone.Dr. Khan previously served as Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, a Fortune 50 company employing upwards of 250,000 employees across 22 brands. At PepsiCo, Dr. Khan played a pivotal role in the company's global R&D efforts to create breakthrough innovations in food, beverages, and nutrition, including the incorporation of healthier and more nutritious offerings across its portfolio. Dr. Khan also oversaw PepsiCo's global sustainability initiatives based on the belief that success in business is inextricably linked to the sustainability of the world we share. Prior to joining PepsiCo, Dr. Khan served as President of Global R&D at Takeda Pharmaceuticals, leading the global efforts of one of the largest pharmaceutical companies in the world by revenue.Before moving into industry, Dr. Khan had a distinguished medical career as a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit. He also spent nine years leading programs in diabetes, endocrinology, metabolism and nutrition in Minneapolis, MN.Dr. Khan is currently a member of the Board of Directors of Reckitt Benckiser.Dr. Khan has also served as a board member in Spectrum Health, CorMedix, HemoShear Therapeutics, and Indigo Agriculture.Dr. Khan earned his medical degree from the University of Liverpool Medical School, England, and completed a fellowship in clinical endocrinology and nutrition in the Department of Medicine and Food Science and Nutrition at the University of Minnesota, Minneapolis. He is a Fellow of the Royal College of Physicians in London and a Fellow of the American College of Endocrinology.#MehmoodKhan #HevolutionFoundation #Healthspan #Lifespan #IntrinsicCapacity #Resilience #Aging #Longevity #Rejuvenation #LifeBiosciences #Endocrinology #GeriatricSyndromes #Nutrition #Xprize #FoodScience #Diabetes #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

In this exciting episode of "The Interventional Endoscopist," I sit down with Scott Haack, a renowned inventor and innovator in the gastrointestinal (GI) space. With a career dedicated to advancing endoscopic technology and improving patient outcomes, Scott shares his journey, the challenges he has faced, and his vision for the future of GI procedures. Tune in as Scott delves into the intricacies of his groundbreaking work, offering insights into the latest innovations and the impact they have on both practitioners and patients. Whether you're an endoscopist, a medical professional, or simply fascinated by medical technology, this episode promises to be an enlightening and inspiring listen. Join me for a deep dive into the world of GI innovation and discover what drives the passion behind Scott Haack's remarkable contributions to the field.   Video of Podcast: https://youtu.be/p2p0gGiVLHI for those who transitioned to the video to watch the innovations discussed by Scott, please forward to 38:00  

Motorola Solutions today announced it is opening a new Research and Development Centre in Cork which is expected to generate 200 highly skilled jobs. The team will be focused on designing software for the company's comprehensive land mobile radio (LMR) portfolio, with plans for expansion across other technologies in the future. Following investments of more than $12 billion in R&D and acquisitions over the past decade, Motorola Solutions' ecosystem of technologies is centred on safety and security, with LMR representing a foundational core. The company has deployed more than 13,000 LMR networks worldwide, trusted by governments and enterprises for highly secure communications designed to work in the most extreme conditions. Modernised with broadband and advanced data applications, LMR remains at the forefront of providing public safety agencies with the communications they rely on and need. "Decade after decade, the durability of our mission-critical LMR technology helps protect those who protect us all," said Greg Brown, chairman and CEO, Motorola Solutions. "Our new centre in Cork will contribute to advancing our future vision for LMR, while building upon the collective impact of our more than 20,000 employees who are innovating what's next for our customers around the world." The investment is supported by the Irish Government through IDA Ireland. "Motorola Solutions is an iconic American company known for its work over many decades to support public safety and first responders," said U.S. Ambassador to Ireland Claire D. Cronin. "Today's announcement of its new Research and Development Centre in Cork marks a significant step forward in the company's commitment to Ireland and in further expanding its innovation footprint in technology that plays a vital role around the world to help keep people safe today and in the future. It also recognizes the highly skilled talent in Ireland and further bolsters the strong trade and investment relationships between the United States and Ireland." The new R&D Centre, planned for Cork's vibrant city centre, complements Motorola Solutions' existing footprint in Ireland, which is focused on delivering the emergency services' secure communications network, Ireland's National Digital Radio Service. "It's fantastic news that Motorola Solutions has chosen Cork City for their new global R&D Centre," said Peter Burke TD, Minister for Enterprise, Trade & Employment. "Regional investment is a priority for Government and the creation of 200 highly skilled jobs in R&D is a significant boost for the region. The new Centre will be a welcome addition to the already thriving city centre and will provide exciting new work opportunities for technology talent. It is encouraging to see new investments in R&D technologies, which is very much in line with our National AI and Digital strategies. I want to thank Motorola Solutions for their continued investment in Ireland and I wish all the team the best with this new venture." "This investment decision by Motorola Solutions to select Ireland and Cork as the location for their new global R&D Centre is an important vote of confidence in the technology sector," said Michael Lohan, CEO of IDA Ireland. "The company's plans to create 200 new jobs demonstrates Ireland's ability to win strategic investments from global leaders looking for a location that can provide a talented and skilled workforce and a track record in delivering innovative, and pro-business environment for multinational companies." The company embraces a people-first philosophy and encourages its 20,000+ employees to share their unique perspectives to influence new ideas, tackle challenges and make an impact. The team in Cork will join a global force of talent focused on developing communications, video security, access control, artificial intelligence and command centre technologies to help address the growing scale of safety and security challenges. Motorola Solutions' communications portfolio is...

We chat with Multiple Award Winning R&B Artist, Tanya Nolan about her new music and her Tiffany Haddish Experience. #michaelfinkleyshow #finkfam #seasonfinale #rnb #rnbmusic #tiffanyhaddish #tanyanolan --- Send in a voice message: https://podcasters.spotify.com/pod/show/michael-finkley-show/message

Ever wonder how a multinational team spanning across Sweden, Japan, France, and the Czech Republic plans their R&D to ensure they deliver game-changing solutions for their customers? This episode sees us chatting with Robert Helleday, Mycronic's Head of Research & Development, who offers a glimpse into their strategic R&D planning which leverages diverse perspectives and skill sets from different parts of the world, alongside the voice of their customers. Robert's insights demonstrate how understanding and keeping the customer's needs at the center of the process is crucial in creating standout products that deliver the maximum value to the user.As the conversation evolves, we wade into the digital age and explore how industries are being transformed by data-driven processes and artificial intelligence (AI). We dive into Mycronic's approach to this change, particularly their integration of AI into their own R&D process. From boosting internal productivity to revolutionizing the inspection process, Robert reveals intriguing ways AI can be used as a tool to free up human time and enhance efficiency in factories.Like every episode of EMS@C-Level, this one was sponsored by global inspection leader Koh Young (https://www.kohyoung.com) and Adaptable Automation Specialist Launchpad.build (https://launchpad.build).You can see video versions of all of the EMS@C-Level pods on our YouTube playlist.

Pre-Show Bad entropy will get your bitcoins stolen (https://nitter.net/mononautical/status/1728946778798793126?ref=nobsbitcoin.com) News This cycle's bitcoin environmental FUD is probably going to be water usage (https://www.theverge.com/2023/11/29/23979858/bitcoin-mine-cryptocurrency-water-use-analysis-energy) Shiny new FUD ammo takes media by storm! (https://stacker.news/items/333497) Rebuttal of BBCNews article, and the Underlying Study, on Bitcoin Water Usage – Batcoinz (https://batcoinz.com/2484-2/) Unchained surveyed US investors and sentiment is very bullish on bitcoin (https://unchained.com/blog/bullish-on-bitcoin-us-investor-outlook-for-btc-in-2024/) Economics What is Global R* (https://bankunderground.co.uk/2023/11/30/global-r/)? And why is it still falling? A Mechanistic model based view of society, humans, and economics is wrong It's not good enough to centrally manage human existence Privacy The US Treasury wants to expand warrantless mass surveillance and sanction free speach via software (https://www.coincenter.org/in-an-effort-to-close-perceived-loopholes-treasury-recommends-massive-expansion-of-warrantless-surveillance-and-power-to-sanction-open-source-software/) in order to strengthen its ability to sanction Bitcoin Education Bitcoin Optech covers liquidity advertisements (https://bitcoinops.org/en/newsletters/2023/11/29/), a feature of dual-funded channels on lightning offered by Core lightning from Blockstream both parties contribute a utxo to a lightning channel liquidity on both sides of the channel at opening Feedback Remember to get in touch bitcoindadpod@protonmail.com or @bitcoindadpod (https://mobile.twitter.com/bitcoindadpod) on twitter Consider joining the matrix channel (https://matrix.to/#/#bitcoin:jupiterbroadcasting.com) using a matrix client like element (https://element.io/get-started), details here (https://www.jupiterbroadcasting.com/community/matrix/) Bitcoin Dad Pod - Pay with you Fav App (https://fountain.fm/show/iSDKQzR5V5DCLn2AuUnI) I sent a boost via Fountain.fm's website Scanned the QR code with my Strike app No Alby or new Podcasting app required! Thank you Boosters If you get some value from this show, please consider sending a boost. Hearing from you means a lot to us! Send a Boost via the Podcast Index web page. No Podcast app upgrade required. Install Alby (https://getalby.com/) Find the Bitcoin Dad Pod on the Podcast Index (https://podcastindex.org/podcast/5049889) Boost right from the page! Send a re-ocurring or one-off lightning boost to the show with no message at bdadpod@getalby.com or directly to Chris at chrislas@getalby.com Value for Value Podcasting 2.0 to support an indepenent podcasting ecosystem (https://podcastindex.org/) Recomended Podcasting2.0 apps: Fountain (https://www.fountain.fm/) podcast app (Android) Podverse (https://podverse.fm/) (Cross platform and self hostable) + Alby (https://getalby.com/) for boosts Castamatic (https://apps.apple.com/us/app/castamatic-podcast-player/id966632553) (Apple) Sponsors and Acknowledgements Music by Lesfm from Pixabay Self Hosted Show (https://selfhosted.show/) courtesy of Jupiter Broadcasting (https://www.jupiterbroadcasting.com/)

The 966 speaks with Dr. Mehmood Khan, CEO of Saudi Arabia's Hevolution Foundation, a global non-profit revolutionizing the healthspan field launched by Royal Decree and chaired by HRH the Crown Prince Mohammed bin Salman. Dr. Khan shares his journey, Hevolution's vision and insights into how he is working to build the organization's operations from the ground up. The 966's conversation with Dr. Khan takes place ahead of Hevolution's inaugural Global Healthspan Summit on Nov. 29-30 in Riyadh, Saudi Arabia. The two-day event at the Four Seasons Hotel promises to serve as a seismic shift in how the world perceives and acts, catalyzing the discussion from lifespan to healthspan.Dr. Khan's interview begins at the 7:55 mark. #Hevolution is headquartered in Riyadh with additional international hubs to support the expansion and execute the global mission. Its vision is to expand healthy human lifespan for the benefit of all humanity.  Hevolution Foundation aims to be positioned as a global leader, catalyst, partner, and convener, to increase the number of scientists entering the field, to increase the investable opportunities in the field of aging, to help shape the regulatory and government environment.Dr. Khan also currently serves as the Executive Chairman of Life Biosciences Inc. where he joined the company in April 2019 as the Chief Executive Officer and Board Member. Life Biosciences was founded to advance scientific research and develop innovative new therapies to improve and extend healthy lives for everyone.Dr. Khan previously served as Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, a Fortune 50 company employing upwards of 250,000 employees across 22 brands. At PepsiCo, Dr. Khan played a pivotal role in the company's global R&D efforts to create breakthrough innovations in food, beverages, and nutrition, including the incorporation of healthier and more nutritious offerings across its portfolio. Dr. Khan also oversaw PepsiCo's global sustainability initiatives based on the belief that success in business is inextricably linked to the sustainability of the world we share. Prior to joining PepsiCo, Dr. Khan served as President of Global R&D at Takeda Pharmaceuticals, leading the global efforts of one of the largest pharmaceutical companies in the world by revenue.Before moving into industry, Dr. Khan had a distinguished medical career as a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit. He also spent nine years leading programs in diabetes, endocrinology, metabolism and nutrition in Minneapolis, MN.Dr. Khan is currently a member of the Board of Directors of Reckitt Benckiser.

 Dave MacAdam is the Director of Portfolio Management for Global R&D at Novelis, the leading producer of flat-rolled aluminum products and the world's largest recycler of aluminum. As director, Dave focuses on optimizing Novelis' global R&D project portfolio, including portfolio and project governance, analytics, and economic modeling. Before joining Novelis, Dave served as an electrical engineer for over 13 years on various aspects of semiconductor design, including product concept modeling, analysis, specification, and design. Dave holds a Bachelor's in Electrical Engineering from the University of Waterloo in Canada, and an MBA from Goizueta Business School at Emory University. Dave also holds 13 patents in multiple areas of semiconductor design.Dave joins me today to discuss navigating innovation challenges for success. He explains change management in portfolio optimization and highlights the role of metrics in strategic decision-making. He discusses the need for resource allocation buffers in portfolio management and outlines the challenges of portfolio prioritization, especially when dealing with constrained resources. Dave also underscores the growing relevance and influence of sustainability on customers' decisions and offers advice to individuals starting their journey in portfolio management.Addendum: The Ball Aluminum Cups Dave mentions in 27:22 are made of 90% recycled content. “Prioritize the change you want and be mindful of the time and investment it takes and of the organization that will use those systems. Keep focused on that as your guiding principle.” - Dave MacAdamThis week on Innovation Talks:●     Dave's role as Director of Portfolio Management at Novelis●     Novelis products in automotive, aerospace, electronics, and construction●     The importance of innovation and sustainability●     What good and bad data look like●     The evolution of portfolios●     Portfolio management in a sustainable world●     Defining the portfolio●     The impact of sustainability on portfolio management●     The push for environmental sustainability in the supply chain●     Challenges related to portfolio prioritization●     Leveraging the right metrics to drive change●     Dave's advice on portfolio management●     Novelis' contributions to sustainable solutions●     Change management in portfolio optimization●     The challenges of driving and sustaining change Connect with Dave MacAdam:●     Novelis●     Novelis on LinkedIn●     Novelis on YouTube●     Novelis on Facebook●     Novelis on Twitter●     Dave MacAdam on LinkedIn This Podcast is brought to you by Sopheon Thanks for tuning into this week's episode of Innovation Talks. If you enjoyed this episode, please subscribe and leave a review wherever you get your podcasts. Apple Podcasts | TuneIn | GooglePlay | Stitcher | Spotify | iHeart | Amazon Be sure to connect with us on Facebook, Twitter, and LinkedIn, and share your favorite episodes on social media to help us reach more listeners, like you. For additional information around new product development or corporate innovation, sign up for Sopheon's newsletter where we share news and industry best practices monthly! The fastest way to do this is to go to sopheon.com and click here. b

Brian Whitlock, Vice President of Global R&D Procurement at Bristol Myers Squibb shares his experience in building a high-performance operating model to support the business objectives of biopharmaceutical research. In the latest episode of the PharmaSource podcast Brian explains how the procurement operating model had to change following 2019, when BMS announced the acquisition of Celgene. “The acquisition was a sea change for how we think about procurement, and how to support a much larger critical R&D business unit with 9,000 scientists worldwide.” he says. Procurement had to align with the priorities for the wider Bristol Myers Squibb business: building a world class pipeline, improving productivity and reducing development cycle times while also delivering high quality medicines to our patients. In order for procurement to support this, Brian explains that “There has been a lot of process reengineering, both internally and with our partners, but also tapping capabilities that exist within the supplier market, that perhaps we have not made a direct investment in.” Brian worked with leaders within R&D function to design an operating model that “not only focuses on driving the high volume, high risk and high visibility opportunities but also have individuals with unique skill sets that can drive an innovation portfolio.” “Procurement played a very important role sitting at the table with our stakeholders to bring those new capabilities to our enterprise.” “One of the things I absolutely love about R&D is we have very creative scientists that come up with challenging opportunities. Every day is different. Every challenge is a little bit unique. It's that variation, and the complexity of these challenges that really motivate us day to day.” The conversation covers the follows: Strategic procurement helps navigate challenging times Cultivate an innovation mindset to increase speed to market Re-designing procurement for speed Deep accountability for your category Innovation comes from smaller transactions One team, serving Patients BMS Prime: Enabling self service The growing importance of Computer Aided Research How important is having a scientific background? Full article here

We welcome Dr Polina R. Ware, Global R&D Director at PPG in today's episode. Having started her career at 3M as an innovator, Polina is an avid predictor of emerging technology trends and white spaces for new markets. While at LANXESS Polina lead Urethane Systems business expansion from Hot Cast Elastomers to participation in the CASE market (coatings, adhesives, sealants and elastomers) as well as new product development in cold cast elastomers. Now at PPG, Polina is on a mission to protect and beautify the world through innovating to engineer out legacy toxic chemicals in metal packaging and developing environmentally friendly chemistries that support circular economy and sustainability.During this episode, we discuss the increasing importance of AI in business and how this is set to shape the packaging coatings sector in the years to comeAs our much-valued podcast sponsors, we're really grateful to PPG for supporting the show. Their range of innovative solutions helps protect and beautify the world.

Sanford Browne is President of Research & Innovation (R&I) at L'Oréal's North American Zone ( https://www.loreal.com/en/usa/news/group/loreal-appoints-sanford-browne-as-president-of-research-and-innovation/ ), where he also serves as a member of the L'Oréal USA's Management Committee, as well as a member of the Global R&I Management Committee. Previous to this role Mr. Browne served as Senior Vice President of R&I for L'Oréal's Asia-Pacific Zone, where he helped build a complete R&I division across the Zone, including the research Hubs of China and Japan, along with Seoul, Bangalore and Singapore, and in addition to R&I, being a great advocate for cultural diversity, Mr. Browne made a strong contribution to developing local researchers throughout L'Oréal's Asia-Pacific zone. Mr. Browne joined L'Oréal in 2013 as Vice President of R&I in China, where he was the major architect of research and strategic partnerships that drove the innovation needed to meet the specific consumer expectations of the market, growing business across all divisions. Prior to joining L'Oréal, Mr. Browne served in various research and leadership roles at Unilever and P&G, and joined the personal care industry right out of University of Waterloo where he studied Biochemistry and Microbiology. Support the show

Dr. Thortsen Fallisch, Head of Global R&D Procurement at Grünenthal spoke to PharmaSource about his experience in setting up a Procurement Centre of Excellence and why speed can be more important than savings. Thorsten joined Grünenthal at an exciting time when it centralised Procurement was a  "new, mostly unshaped  function". It meant he could make a real impact on the function and see the improving results. Establishing a Sourcing Board One of the first areas they identified was that there was not  a standardised process for the category managers to do sourcing activities  “Tenders sometimes only invited three or even one vendor because it was clear from the very beginning who would be the 'Chosen One', often driven by stakeholders” Thorsten introduced a Sourcing Board council where the category managers had to present how they are planning to run that tender.  To support that process, they introduced the governance that for any tenders over €100,000 Euros would  need to have at least three valid offers. A methodology was agreed in advance agreed for how the offers would be evaluated. For example, procurement would want 50% of the weighted criteria to be price or costs associated with the tender. "The category manager could the run the tender, and when they had decided which vendor to take, they had to come back to the sourcing board and get the final approval." "This framework helped to structure the process and created a lot of transparency about what was being worked on. " To embed this required a lot of personal energy to guide and support team members through the process and communication. With a geographically dispersed team they put a lot of efforts on our on fostering our internal community through their intranet. “This starting off with a page and a bit of content,  over time, we developed a real plan, with a fortnightly newsletters and regular Townhalls with the teams. “ How technology was used to enable change The process started by being managed in Excel and PowerPoint documents, with sourcing mangers completing templates to present their case to the Sourcing Board. The next step was a tool Grünenthal developed themselves specifically to manage the sourcing process, where all information previously in PowerPoint could be put in the tool.  Finally, they implemented an E-Procurement platform. After  evaluating a number of vendors they before decided to use Jaeger,  a platform they have been using for the last two years.  Why speed is more important than savings Since moving into a new role focusing on R&D, Thorsten has continued to play a role in the development of the Sourcing Board so that it partners better with his new stakeholders. His main objective has been to accelerate the process.  “To understand the friction with R&D and Procurement you have to understand one thing…  Speed is more important than savings” "The faster you develop a drug, the more time you have left on the market. That's why  Grünenthal as a company deliberately took the approach to to conduct some of the R&D studies in parallel and prioritise speed." The Sourcing Board approach was perceived as delaying the process too much, so now a faster process involves the stakeholders earlier to make decisions.  "We now call it the 'Category Council' which is now a more stakeholder-oriented way of taking vendor decisions. So it's not only the sourcing board and procurement internal council that approves a decision on the vendor, but stakeholders are closely involved throughout" "Prioritising speed is an interesting challenge for someone in procurement to have! Not to focus on savings but on speed makes a nice change.” says Thorsten. https://pharmasource.global/content/podcast/how-to-create-a-procurement-centre-of-excellence-a-conversation-with-dr-thorsten-fallish/

Offline nach Erpressungsversuchen: Cyberangriffe auf Unternehmen und Krankenhäuser oder zuletzt auch die Stadt Potsdam nehmen zu. In unserer aktuellen Folge zu „IT Security und Cyber-Resilienz“ erläutert Lola Attenberger, Global R&D Software Security Engineer bei Carl Zeiss, wie sich Unternehmen schützen können. In der Software wird IT-Sicherheit von Anfang an mitgedacht: Es geht um Sicherheitslücken auf technischer Ebene, um die Security-Kultur, um Sicherheitskonzepte. Erste Voraussetzung sind Risikoanalysen und Klarheit über kritische Abhängigkeiten genauso wie die kritische Infrastruktur. Was der Shift-Left-Ansatz beinhaltet, wieso eine agile Organisation hilfreich ist und inwieweit auch öffentliche Einrichtungen betroffen sind: Hören Sie selbst. www.managerkreis.de www.fes.de www.linkedin.com/company/managerkreis-fes/ twitter.com/mk_fes

Synopsis: John LaMattina is the former President of Global R&D at Pfizer and is currently a Senior Partner at PureTech Health. A self-proclaimed defender of the pharmaceutical industry, Dr. LaMattina worked at Pfizer for 30 years before joining the biotech industry as a board member for a variety of different biotech companies. His recently published book, “Pharma and Profits”, talks about the misconceptions around COVID-19 vaccines and other areas including the cost of drugs, and the impact that the passing of the IRA Act will have on R&D going forward. In this episode he also discusses how biotech leaders should be thinking about the new IRA Act legislation and what changes they should anticipate. Biography: Dr. John L. LaMattina is the former Senior Vice President, Pfizer Inc and President, Pfizer Global Research and Development. In this role, Dr. LaMattina oversaw the drug discovery and development efforts of over 13,000 colleagues in the United States, Europe and Asia. He retired from this position in December, 2007. Dr. LaMattina spent 30 years at Pfizer Inc having joined as a medicinal chemist in 1977. Over the years, he held positions of increasing responsibility for Pfizer Central Research, including Vice President of US Discovery Operations in 1993, Senior Vice President of Worldwide Discovery Operations in 1998 and Senior Vice President of Worldwide Development in 1999. Dr. LaMattina graduated cum laude from Boston College in 1971 with a B.S. in Chemistry. He attended the University of New Hampshire receiving a Ph.D. in Organic Chemistry in 1975. He then moved on to Princeton University as a National Institutes of Health Postdoctoral Fellow in the laboratory of Professor E. C. Taylor. During his tenure as head of global R&D, Pfizer produced new treatments for cancer, smoking cessation, rheumatoid arthritis and AIDS. Dr. LaMattina is the author of numerous scientific publications and holds a number of U.S. patents. In addition, he is the author of Drug Truths: Dispelling the Myths About Pharma R&D and Devalued and Distrusted – Can the Pharmaceutical Industry Restore Its Broken Image? He is also a Forbes contributor. Dr. LaMattina has received a number of awards including the 1998 Boston College Alumni Award of Excellence in Science, the 2007 Equal Opportunity Award from Legal Momentum, an Honorary Doctor of Science degree from the University of New Hampshire and the 2010 American Chemical Society Earle Barnes Award for Leadership in Chemical Research Management. Dr. LaMattina is a Senior Partner and a member of the Board of Directors of PureTech Health. He serves on the Board of Directors of Ligand Pharmaceuticals, Immunome and Vedanta. Dr. LaMattina also serves as a Trustee Associate on the Board of Trustees of Boston College.

ICIS Senior Editors for Recycling Matt Tudball in London, Arianne Perez in Singapore and Emily Friedman in Houston discuss how global R-PET markets went from record-high prices to major price drops, from extreme tightness to over-supply, and how the impact of legislation will become increasingly felt across the regions in 2023 and beyond. 

For part 2 of this mini-series, I was honored to be joined by Mr. Brad Carlson, the General Manager & Global R&D leader at LivaNova.Brad has spent the last 12+ years in the Med-Tech industry holding roles like VP of Engineering, VP of R&D, VP of Innovation Strategy, and General Manager from some of the world's leading Med-Tech companies like Danaher, Envista Holdings, and now LivaNova.For those unfamiliar with LivaNova, it is a global med tech organization with a diverse product portfolio with therapies for the head and the heart.The company has a presence in more than 100 countries and employs approximately 3,000 people.In similar fashion to our episode with Patrick Stephens at Shockwave Medical, here are some of the highlights of what Brad & I discussed:-Why did you get into Med-Tech in the first place?-What was your childhood/early years like? What held your interest?-Looking over the course of your career to date, what are some of the pivotal moments that you think really helped you move up in the leadership ranks to get to where you are today?-What do you enjoy most about leadership?-How do you spot top performers? What do you look for?Is there a theme you can point to?- What career/life advice would you give to someone who is driven to become an R&D Exec like yourself...and much more!Feel free to discover more about Brad & LivaNova:Brad Carlson on LinkedIn: https://www.linkedin.com/in/drbradleyscarlson/LivaNova on the web: https://www.livanova.com/en-us

Scott Brun, MD, began his long career in pharma R&D leadership in the late 1990s, holding key roles at Abbott and AbbVie. Had he picked up a pencil with his right hand, his career may have taken a completely different turn.Dr. Brun earned his medical degree at Johns Hopkins University School of Medicine and completed a residency in ophthalmology at the Massachusetts Eye and Ear Infirmary. A leftie, Dr. Brun ultimately decided not to become ambidextrous. Instead, he joined Abbott as a pharmaceutical physician and began a fruitful career leading development across multiple therapeutic areas.With OIS Podcast host Sophia Pathai, MD, PhD, Dr. Brun looks both forward and ahead, sharing stories from his time at Abbott and AbbVie as well as his insights on promising developments in ophthalmology. At venture capital firm Abingworth, Dr. Brun currently helps young biopharma leaders turn their visions into reality. He's also running his own consulting company and helping Horizon Therapeutics build its internal pipeline.Listen to the podcast today to hear Dr. Pathai and Dr. Brun talk about:Dr. Brun's background, from medicine to industry to consulting and VC work. Pivotal events across therapeutic areas during his tenures at Abbott and AbbVie.  How Dr. Brun fostered teamwork, motivation, and engagement among large teams within large pharmaceutical companies, especially in times of failure. The differences between managing a team of six and leading an organization of 2,000 people across 40-plus countries.The success of Opthea and how it illustrates the need for VCs to think globally. How the current bear market will test early-stage biopharma and biotech, and how these startups can survive current economic challenges. The road ahead. What areas of development look most promising? Gene therapy for dry age-related macular degeneration? Ganglion cell regeneration? Something else?Click “play” to listen.

John LaMattina, PhD, former president of Pfizer Global R&D, discusses his most recent book "Innovation, Medicine & Drug Prices" https://www.amazon.com/John-L-LaMattina/e/B001JSHGZ4/ref=aufs_dp_fta_dsk Please support The Business of Pharmacy Podcast™ by checking out our sponsors at https://www.bizofpharmpod.com.

October is cybersecurity awareness month but there's still a major gap in women working in cyber security. We speak with Global R&D Lead for Security at Accenture, Lisa O'Connor, about what's being done to help women get involved and climb the ladder. ((00:00)) This week is fire prevention week and we spoke with Bridgeport Fire Chief Lance Edwards about what you can do to best prepare for a potential house fire. ((12:07)) We wrap up our coverage for breast cancer awareness month, talking about breast health and reconstruction surgery. Plastic surgeon, Dr. E. Stirling Craig shared who is eligible for the surgery, what it entails and the chances of eliminating cancer after surgery. ((27:13)) A softball coach is making mental health a priority with his athletes. We spoke with Stratford High School Softball coach, Gary Sherrick, about why he took on this method of coaching, even before the pandemic. ((35:20)) Image Credit: Liudmila Chernetska / iStock / Getty Images Plus

The decisions by major food companies impact consumers, farmers, and the environment at every stage of the agrifood value chain. But the status quo strategies of ‘Big Food' don't always acknowledge the complex, interconnected systems at play around the world.Our guest this week is Dr. Nigel Hughes, Senior Vice President of Global R&D at Kellogg. After spending a career in what he would unwillingly call Big Food, Nigel now advocates for the urgent recoupling of the many smaller systems, from farming to processing to distribution, that have become detached as they've been optimized over decades.For more information and resources, visit our website.

In this podcast we feature Professional Scrum Trainers and other Scrum Practitioners sharing their stories and experiences to help learn from the experience of others. In this episode, host Dave West interviews David Ingram, VP of Global R&D at Gillette about developing razors using Scrum and how they transitioned to Scrum to do so. 

Due to an enthusiastic response from early podcast listeners, we're reairing ‘Attached to Hygiene' episode 11: The Hygiene Market in 2035. This popular episode features Nick Carter, Vice President, Nonwovens Marketing at Avgol Nonwovens; DeeAnn Nelson, NA-R&D and Innovation Manager at Avgol; and Darius Deak, Global R&D Director for Bostik. Along with host Jack Hughes, they make predictions about the future of the nonwovens industry. Demographics and market trends in absorbent hygieneHow will the absorbent hygiene industry look in 2035? Jack and the three experts consider where the current trends are leading us based in part on market shifts being observed with Millennials and Gen Z consumers. For example, the Millennials are having children later than previous generations, or not having them at all. That mindset, along with ‘Black Swan' events like COVID-19, has resulted in the number of babies being born dropping significantly. This trend started in the 1980s and continues into the present day. Many Millennials are instead focusing on their pets, or ‘fur babies', which means there has been a shift from growth in baby care to pet care products. Also, the trend of e-commerce is playing a much bigger role in purchasing decisions. On the other end of the spectrum, the aging population is growing. This will likely result in more potential for the adult incontinence market. The impact of legislation and the need for sustainability More and more, consumers are seeking sustainable products. However, the legislation that is pushing for changes regarding single-use articles is sometimes getting ahead of the technology needed for the product to adapt. One example: Mexico City instituted a tampon ban before manufacturers were prepared with alternatives. Other times there are unintended consequences of legislated changes, such as a region's water source being unable to support a product like a reusable diaper. Both offer challenges and opportunities for producers and suppliers, who have to be ready with innovations.Outline of the Episode[02:09] Introduction of guests and overview of their backgrounds [08:11] Avgol's presentation at Hygienix 2020 as inspiration for episode[09:11] Market demographics in the absorbent hygiene industry[12:09] Millennials are putting off or choosing not to have children[15:19] Purchasing trends, such as e-commerce, of Gen Z[20:22] How legislation is outpacing technology[27:05] ‘Black Swan' events like COVID-19 and their effect on the market[36:30] Being sustainable whilst offering a product that meets consumers' needs[41:17] What are Avgol and Bostik doing to address the changes in the marketplace?Recommended ResourcesContact Nick on LinkedIn.Contact DeeAnn on LinkedIn.Contact Darius on LinkedIn.To learn more about the trend of sustainability in the industry, read our article ‘Is There a Sustainable Future for Disposable Hygiene?'Get Connected with Attached to HygieneTake our Listener Survey to receive an early copy of our CSR Whitepaper.Connect with Jack Hughes on LinkedIn. You can also find us at Disposable Hygiene Adhesives on LinkedIn or by visiting the Attached to Hygiene Podcast on our official website. Email us with questions, comments, or ideas for future episodes at hygiene@bostik.com. Host: Jack HughesMusic by Jonathan BoyleProduced and edited by: Jack Hughes with help from Paul Andrews, Michele Tonkovitz, Emory Churness, and Nikki Ackerman from GreenOnion Creative.

Dr. Tristin Brisbois, Ph.D., (https://www.linkedin.com/in/tristin-brisbois-6b352b56/) is Director, Advanced Personalization Ideation Center, Life Sciences, Global R&D, at PepsiCo (https://www.gssiweb.org/en/about/pepsico-life-sciences), where she is involved in delivering actionable personalized nutrition solutions to promote the health and wellness of their consumers (https://pepsicohealthandnutritionsciences.com/). She also recently held the role of Director, Platform & Academic Partnerships, where she was involved in translating strategic intent and science-based analyses into actionable work plans and optimal project portfolio to meet PepsiCo's short and long-term needs. This included developing internal capabilities, such as personalized nutrition, as well as identifying and forming key partnerships with leading academic institutions and external vendors. Dr. Brisbois previously served as a Senior Principal Scientist for Global R&D Nutrition Sciences, where she was involved in advancing the translation of nutrition science in key areas, directing and guiding regional product innovation and brand communications for PepsiCo North American beverages. She also provided expert input and support on external stakeholder issues and oversaw PepsiCo North American nutrition communication outreach program and strategy. Prior to working for PepsiCo, Dr. Brisbois was the Manager of Nutrition and Scientific Affairs at the Canadian Sugar Institute, where she led the Institute's nutrition communications program. Dr. Brisbois completed her PhD and BSc (in Nutrition and Food Science) at the University Alberta. Her PhD investigated food intake behavior in cancer with a focus on appetite stimulation and improvement of taste and smell perception using marijuana therapy. She studied appetite and reward related pathways in healthy and disease populations, and explored mechanisms which may cause a surfeit (obesity) or deficit (cancer) of calories. Dr. Brisbois also has a Masters of Business and Science (MBS), in Global Food Technology and Innovation, from Rutgers University.

Dr. Patricia Verduin, PhD, (https://www.colgatepalmolive.com/en-us/snippet/2021/circle-cards/our-leadership/patricia-verduin) is Chief Technology Officer for the Colgate-Palmolive Company where she provides leadership for product innovation, clinical science and long-term research and development across their Global Technology Centers' Research & Development pipeline. Dr. Verduin joined Colgate Palmolive in 2007 as Vice President, Global R&D. Previously she served as Vice President, Scientific Affairs, for the Grocery Manufacturers Association, and from 2000 to 2006, she held the position of Vice President, Research & Development, at ConAgra Foods. Dr. Verduin started her career with 17 years at Nabisco, serving in multiple roles, including plant manager and scientist. She earned her undergraduate degree from the University of Delaware, holds an MBA from Fairleigh Dickinson University and a PhD in Food Science from Rutgers University. Colgate-Palmolive Company (https://www.colgatepalmolive.com/) is an American multinational consumer products company specializing in the production, distribution and provision of household, health care, personal care and veterinary products, with a mission of re-imagining a healthier future for all people, their pets and our planet.

Alors que l'exode de la capitale vers des terres rurales ne se fait plus rare depuis quelque temps, elle avait déjà pressenti un besoin de retour aux choses plus simples. Au gré des saisons, la rédactrice en chef du magazine Regain Daphné Hézard met en lumière la vie à la campagne sous toutes ses formes depuis 2018. En terres rurales ou près de la mer, elle offre à travers ce journal un regard sans filtre sur ce que génère la nature. Des savoir-faire agricoles anciens, des engagements politiques et citoyens aux métiers de la terre, Regain célèbre avec poésie un rapport à la nature sain et fécond. Pourtant, rien ne prédestinait la journaliste autodidacte à cette voie. Rédactrice en chef de L'Officiel, présentatrice de l'émission activiste et écologiste Global Résistance et plus récemment editor at large pour le magazine Monocle, Daphné est ce genre de personnalité insatiable qui a eu mille vies en un laps de temps. Dans cet épisode, elle nous parle de sa carrière dans la presse féminine, de sa vision éditoriale et entrepreneuriale du média. Rendez-vous avec Daphné en terre rurale, où la beauté de la nature n'a jamais fini de vous époustoufler… «Pourquoi aller s'entasser dans les villes où la qualité de vie est vraiment dure et très chère alors qu'il y a plein de choses à faire dans les villages ?» Ce que vous allez apprendre dans cet épisode : Daphné se présente Ses premières expériences et ce qu'elle en retient Sa carrière entre la presse et l'audiovisuel Son expérience chez Jalouse Magazine Son expérience chez L'Officiel Magazine et L'Officiel Voyage Son expérience de productrice télé Ses débuts chez Monocle avec Tyler Brûlé Ses missions et les codes du média Comment elle reste informée ? La genèse de Regain La distribution et le modèle économique Ses apprentissages autour de ce projet La ligne éditoriale du magazine Son agence de création Sa vision pour Regain L'impact que génère Regain Comment elle briefe ses journalistes ? Qui elle souhaiterait entendre dans ce podcast ? Ses conseils pour Réuni «Arrêter le support papier dans la presse reviendrait à arrêter toute une industrie et toutes les valeurs que Regain véhicule.» «Notre mission est de réduire la distance avec le monde paysan et de rappeler ce qui se faisait à l'époque.» «La fermeture d'un bistrot, c'est la mort d'un village. Des restaurants ou des auberges fermées qui ne demandent qu'à renaître, il y en a dans toute la France.» N'oubliez pas de vous inscrire à la newsletter de Entreprendre Dans La Mode, les industries créatives et l'art de vivre sur www.entreprendredanslamode.com Aussi, si vous souhaitez me contacter ou me suggérer de nouveaux invités, vous pouvez le faire sur Instagram sous le pseudonyme @entreprendredanslamode Enfin, le plus important : laissez-moi un avis sur Apple Podcast ou iTunes, 5 étoiles de préférence ; cela m'aide à faire connaître le podcast à plus de monde et me motive à faire de meilleures interviews ! Merci de soutenir ce podcast et à bientôt pour un nouvel épisode ! Références : Regain Magazine : https://www.regain-magazine.com @regainmagazine : https://www.instagram.com/regainmagazine/ Façonnable : https://www.faconnable.com/fr_eu/home Wallpaper : https://www.wallpaper.com @jalousemag : https://www.instagram.com/jalousemag/?hl=fr L'Officiel : https://www.lofficiel.com Monocle : https://monocle.com Monocle Radio : https://monocle.com/radio/ Winkreative : https://www.winkreative.com Konfekt Magazine : https://konfektmagazine.com Rustica : https://www.rustica.fr Modern Farmer : https://modernfarmer.com House And Garden : https://www.houseandgarden.co.uk Terre et Fils : https://terreetfils.org Jean Giono, Regain : https://www.babelio.com/livres/Giono-La-triologie-de-Pan-tome-3--Regain/1101794

Olá, pessoal.. 2022 começou e o @UmDiaPod tá de volta e o Math parece MUITO pra baixo. A Jaque descobriu que ele ficou assim por causa desse lance da guerra entre Rússia e Ucrânia. Questões de território e poder militar e... Como assim? Você só sabia que tem uma guerra acontecendo. Não tá por dentro dos motivos e tal. Então vamos usar o episódio de hoje pra falar sobre isso. Aperta o play porque tá começando mais um episódio do UmDiaPod! E aí, galera? Aprenderam com esse primeiro episódio com @UmDiaPod de 2022? Comenta lá no nosso instagram @UmDiaPod sem E ou I no final! E segue o nosso Tik Tok!

Et brev, der angiveligt stammer fra en russisk whistleblower, med tilknytning til den russiske efterretningstjeneste, FSB, beskriver et Rusland, som er i store vanskeligheder i kølvandet på invasionen af Ukraine. Global hungersnød, russisk statsbankerot og en krig som Rusland ikke kan vinde. Vi dykker ned i de centrale påstande og efterprøver dem med en række eksperter. Værter: Cecilie Lange og Alexander Wils Lorenzen.Redaktør: Christine Randa

New Talk Art!!! We meet a GLOBAL LEGEND, our dear friend, the iconic recording artist, three-time Grammy winner, and global R&B superstar, MAXWELL!!!!!! We discuss Maxwell's musical journey, collecting art, visiting Frieze New York art fair where he first expeirenced Hans Op de Beeck's Silent Library (2016) immersive installation, his love for artists Nina Chanel Abney, Steve McQueen, Seydou Keita and Jon Key, covering the iconic Kate Bush song 'This Woman's Work'. We discover his passion for drawing and amazing advice his art teacher gave him in his childhood. His admiration for Tracey Emin's neons and a trip to the Whitney with Robert where they met Tracey. We explore the text works of Massimo Agostinelli and Max's admiration for the artistry of the late fashion designer Alexander McQueen and his memories from visiting his major retrospective at the Met. We discuss his deep respect and friendships with icons Prince, Harry Belafonte, Alicia Keys. We also hear about the passionate motivation behind Maxwell's new fundraising sunglasses collection. Finally, we remember Russell's epic 1990 Heinz ketchup TV advert and our mutual LOVE for our pal & leading British actor Lydia West.Maxwell has artfully managed to transfix music lovers for more than two decades, releasing five studio albums, all in his own time and all duly anointed as classics. The soul singer redefined soul music in April of 1996 when he released his critically acclaimed debut on Columbia, 'Maxwell's Urban Hang Suite.' It earned Grammy nominations, double platinum status and RIAA gold for the single, "Ascension (Don't Ever Wonder)." The platinum albums 'Embrya' (1998) and 'Now' (2001) followed. After eight years, 2009's 'BLACKsummers'night' debuted at No. 1 on the Billboard 200 and won two Grammys, including Best R&B Album.To date, Maxwell has achieved 4 platinum album certifications from the RIAA. His last album ‘blackSUMMERS'night,' the second instalment of his musical trilogy, earned Maxwell his third Grammy (Best R&B Song for “Lake By The Ocean”) an NAACP Image Award (Outstanding Male Artist), and a Soul Train Award (Best R&B/Soul Male Artist). Recently honoured with the “Legend” Award at the 2021 Soul Train Awards, Maxwell's upcoming ‘blacksummers'NIGHT' is one of the most-anticipated R&B events of 2022 and will cap off a journey he first embarked upon over a decade ago. In Feb 2022, STATE Optical Co. launches their collaboration on limited-edition sunglasses designed with Maxwell! The STATE x Maxwell BLACK_SUMMERS'_NIGHT titanium sunglasses will be available for exclusive pre-sale starting Monday, February 14th, Valentine's Day. Its wide launch will be on March 1st. More here: https://store.musze.com/collections/sunglassesMaxwell can be seen flaunting the new style in the music video for his current Top 10 R&B single, “OFF,” an exciting preview of what's to come for the highly-anticipated release of ‘blacksummers'NIGHT,' the final chapter in his critically acclaimed album trilogy. Also keep an eye out for the style as Maxwell kicks off his 25 date NIGHT Arena tour in March 2022. STATE Optical Co. Expands Limited Edition Collab with Global R&B Superstar Maxwell Launching March 1 (Exclusive Pre-Sale to Launch February 14) | Portion of Proceeds to Support the Opening Your Eyes Scholarship. Maxwell's highly anticipated new album blacksummers'NIGHT will be released in Spring 2022.Follow @Maxwell on Instagram for latest details on his new album and tour, as well as Maxwell's official website: https://Musze.com/ See acast.com/privacy for privacy and opt-out information.

This Fresh Take interview featured Neelima Rao, Vice President Human Resources, Global R&D and North America HUB Leader, AstraZeneca. JB Holston and Neelima discussed the business imperative of inclusive growth, her focus on developing a skilled and diverse talent pool to drive innovation, and more.Hosted by JB Holston.  Produced by Jenna Klym, Justin Matheson-Turner, Christian Rodriguez, Nina Sharma, and Ramir Cena. Edited by Christian Rodriguez. Learn from leaders doing the work across the Capital Region and beyond. These conversations will showcase innovation, as well as history and culture across our region, to bridge the gap between how we got here and where we are going.About our guest:Neelima Rao is Vice President of Human Resources for Global Oncology R&D and North America Country Lead at AstraZeneca. In this role, Neelima is responsible for defining and implementing workforce and workplace strategy across multiple geographies globally. Neelima serves as the HR Chair of the AstraZeneca North America Governance Committee.Neelima brings over 20 years of experience driving successful change, growth, and innovation across complex and global organizations in the Life Sciences industry. She has led large-scale transformational agenda in acquisition, ramp-up, turnaround and integration environment. Neelima is passionate about driving business outcomes through designing fit-for purpose organizations, building high performing teams and shaping desired cultures.Neelima has a Master's degree in human resources from Tata Institute of Social Sciences, Mumbai. Neelima currently serves on the board of AWIS (Association for Women in Science), passionately promoting women around the world to pursue their STEM education and professional goals. Neelima has been serving as an Inclusive Growth Committee Advisor for Greater Washington Partnership, a civic alliance focused on catalyzing equitable solutions that make the region the best place to live, work, and thrive.

Selling a product to a buyer in today's market can be difficult with so many competitors offering similar solutions. The tendency is to differentiate yourself by providing detailed product messaging, but this isn't always the case.In this episode of our Takeover series, we hear an episode from Emisary's "ABM Mythbusting Series".Bernard Brower, Former VP IT North American Consumer Group, Global R&D - J&J, discusses what a buyer is really looking for and how to foster future sales. Bernard covers:Missing the mark with product messagingTipping the scale with similar productsHow a marketer stays top of mindWhat to look for in a product pilot This is a #FlipMyFunnel podcast. Check us out on Apple Podcasts, Spotify, or here.Listening on a desktop & can't see the links? Just search for Flip My Funnel in your favorite podcast player.

How will the nonwovens industry look in 2035? From a declining birth rate to unexpected world events to regulations, “business as usual” may be substantially different in just over a decade. In this episode of “Attached to Hygiene,” host Jack Hughes delves into predictions with three long-time players in the industry: Nick Carter, Vice President, Nonwovens Marketing at Avgol Nonwovens; DeeAnn Nelson, NA-R&D and Innovation Manager at Avgol; and Darius Deak, Global R&D Director for Bostik. Together they use their decades of experience to make informed projections for the disposable hygiene market. Highlights include:The influence of purchasing decisions and lifestyle choices by Millennials and Gen Z consumers How outside factors such as legislation could change the industryWhat products and new innovations will look like in the futureHow “black swan” events like COVID-19 will play a roleThe growing focus on trends such as sustainabilityRecommended ResourcesContact Nick on LinkedIn.Contact DeeAnn on LinkedIn.Contact Darius on LinkedIn.Host: Jack HughesMusic by Jonathan BoyleProduced and edited by: Jack Hughes with help from Paul Andrews, Michele Tonkovitz, Emory Churness, and Nikki Ackerman at Green Onion Creative.

I speak with Dr. Nilesh Shah, the former Global R&D Director at Dow Chemical about sustainability and circular economy. (0:00) Nilesh Shah's biography (1:02) Defining sustainability and circular economy (3:20) The impact of chemical products on greenhouse gas reductions (7:00) Incongruity between plastics' net positive impact on the world and the media's portrayal of plastics (12:08) Responsibility of various players in the plastics ecosystem (15:45) Achieving circular economy via incremental and breakthrough solutions (18:16) Examples of short term incremental solutions (20:53) Economic viability of short term solutions (22:29) Role of legislation and regulation in sustainability efforts (25:12) Process of removing harmful chemicals off the market (27:54) When regulatory bodies tend to step in (30:05) What it takes for sustainable alternatives to be adopted (31:08) Importance of systems thinking in achieving sustainability

Abhi Seth started his journey as an industrial engineer which he describes as his passion, and then found his way into research. His PhD is in mechanical engineering, and human-computer interactions, which he says was kind of a double major PhD. Abhi started working with virtual reality applications for mechanical engineering and says back then it was about how to simulate environments and models where you create a suspension of disbelief for a user. So he set out to prove that VR was also valuable in solving real industrial problems which led him to join the Global R&D centre for Caterpillar, the world's largest mining construction equipment manufacturer. Abhi currently leads a global data analytics team for TE Connectivity, a $14B electronics manufacturing company. He says he is always up for a challenge and learning something new, one of the reasons he decided to join TE Connectivity. We learn from Abhi about the purpose of centres of excellence, the differences between data science COE, and a centralized department and how do you measure success with analytics. Enjoy the show! Read the full episode summary here: Ep 162 Thank you to our sponsor, Talent Insights Group. --- Send in a voice message: https://anchor.fm/datafuturology/message

Då stod Johan Norberg och America Vera-Zavala på var sin sida om barrikaden i den intensiva globaliseringsdebatten. Tillsammans skrev de boken Global rättvisa är möjlig. Vad har hänt sedan dess med debatten kring globalisering, rättvisa och handel? Och vad tycker de idag? Vi sammanförde Johan och America för ett nytt samtal – 20 år senare. Johan Norberg blev symbolen för den nyliberala synen på utvecklingen, America Vera-Zavala den som representerade vänstern och Attac-rörelsen. Tillsammans skrev de (från varsitt håll) boken Global rättvisa är möjlig som blev en viktig temperaturmätare på globaliseringsdebatten i en tid då 9/11 ännu inte ägt rum och den första smarta mobilen väntade på att tillverkas. Vad har hänt sedan dess – med debatten, med Sverige och med världen? Hur ser vi på globaliseringen idag? Vi förde samman Johan Norberg och America Vera-Zavala till ett nytt samtal. Vilka skatter tycker Johan det behövs idag, vad tycker America om hur vänstern förändrats? Står de fasta vid sina åsikter från 2001? och framför allt – blev det någon global rättvisa? Medverkande: Johan Norberg. Då: liberal debattör verksam vid Tibro. Idag: författare och alltjämt liberal. America Vera-Zavala. Då: Frontfigur i Attac och Ung Vänster. Idag: dramatiker med starkt engagemang mot rasism. Programledare: Ylva Bergman och David Isaksson.

We speak with Scott Collick and Lindsey Karpowich from DuPont. Scott is Vice President of Global R&D for Transportation and Industrial and Lindsey is New Product Development Agile Coach. We delve into DuPont’s Dead Projects Day, a day where they specifically share and work through Dead Projects. DuPont knows that learning from mistakes and making sure others can learn and pivot their innovative project because of known mistakes is so helpful. But there must be a culture where brilliant failures are celebrated or learned from, not swept under the rug and ridiculed. Innovation, trying new ideas, is a fail game; it is natural, helpful, and company’s ought to create a safe space for sharing innovation struggles and failures so that people can brilliantly fail as well as brilliantly succeed, because they actually go hand in hand. For more information, visit our website: https://untoldcontent.com/ You can also find us on Instagram: @untoldcontent

In this episode, I'm in conversation with the hugely successful Gavin Bown, Vice President for Global R&D at the world's leading chocolate and cocoa manufacturer, Barry Callebaut. Join us as we discuss Gavin's career in the FMCG industry, how to successfully manage a large international team whilst remote working and what great leadership looks like within high-performing organisations. We talk through Gavin's success within the FMCG industry and the traits and behaviours that helped him along the way. While talking about the importance of a continuous learning mindset, Gavin explains he is 'allergic to his comfort zone' and constantly pushes to further develop himself. He also provides some valuable knowledge on successfully managing an international team whilst remote working. He stresses how vital it is to provide team members with clarity and purpose but also the freedom to make decisions (and mistakes), which he believes is crucial for their development. In this insightful episode, we also navigate through conversations about the future challenges facing the industry, the importance of establishing a culture of trust and destigmatizing failure. Enjoy! If you'd like to get in touch for any reason, feel free to drop me a message on LinkedIn: linkedin.com/in/jonathan-o-hagan-

In this episode of the OIS Podcast we get to hear another panel discussion from the last OIS@AAO meeting in San Francisco. Emmett T. Cunningham Jr., MD, PhD, MPH, led a great discussion about Innovating Around the Globe with 2 international Venture Capitalists and 3 industry executives from Alcon, Santen and Novartis.Participants:Laurent Attias, SVP, Corporate Development Strategy, BD&L and M&A - AlconMichael Keyoung, MD, PhD, Managing Director & Head, North America - CBC GroupGiovanni Mariggi, Partner - MedicxiNaveed Shams, MD, PhD, Head, Global R&D, Chief Scientific Officer, Senior Corporate Officer - SantenJehan Tamboowalla, VP, Head of New Products, Ophthalmology - NovartisModerated By:Emmett T. Cunningham Jr., MD, PhD, MPH, Senior Managing Director - Blackstone Life SciencesJoin us this year at the 12th Annual OIS – November 12, 2020 » Las Vegas, NVhttps://ois.net/12th-annual-ois

Our guest: In this episode, we speak with Robert Cohen, VP of Global R&D, Chief Technology Officer at Stryker Joint Replacement. Stryker is one of the world's leading medical technology companies, and is leading the development of new ways to transform and enhance the technology available in musculoskeletal care.   Robert shared some insights on the work Stryker is doing to improve surgical practice as well as capture more and better data about patient outcomes. We dive into the latest information about surgical robots, wearable sensors, and data, and explore the advances that may develop over the next 10 years.   Links and Resources: Robert Cohen on LinkedIn   Stryker on LinkedIn Stryker Orthopaedics on the Web Stryker Mako Technology Stryker Joint Replacement Smart Equipment Mgmt (Stryker) HoloLens in Germany (Virtual Surgery Intelligence) Microsoft Health  Website • Twitter  Link to Episode 96 with Molly McCarthy The Venue: This conversation was recorded at DOCSF in January 2020, the weekend before #JPM Week in San Francisco. DOCSF is all about the intersection of digital health and musculoskeletal care. This year, the sessions featured leaders from Microsoft, Google, Mozilla, Amazon and many other amazing organizations, and Dan Kendall interviewed some of the speakers following their sessions on the stage. This special series of episodes features some of the interviews recorded at this annual event. To hear all the sessions on the DOCSF podcast, be sure to subscribe to the DOCSF Podcast here or visit Health Podcast Network. Get more content: Browse episodes on Digital Health Today  Browse episodes on the DOCSF Podcast Follow Digital Health Today on Twitter, Linkedin, Facebook and Instagram Follow the Health Podcast Network on Linkedin, Twitter, Facebook and Instagram   Digital Health Today is made possible by the support of our sponsors. Thank you to Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics

Our guest: In this episode, we speak with Robert Cohen, VP of Global R&D, Chief Technology Officer at Stryker Joint Replacement. Stryker is one of the world's leading medical technology companies, and is leading the development of new ways to transform and enhance the technology available in musculoskeletal care.   Robert shared some insights on the work Stryker is doing to improve surgical practice as well as capture more and better data about patient outcomes. We dive into the latest information about surgical robots, wearable sensors, and data, and explore the advances that may develop over the next 10 years.   Links and Resources: Robert Cohen on LinkedIn   Stryker on LinkedIn Stryker Orthopaedics on the Web Stryker Mako Technology Stryker Joint Replacement Smart Equipment Mgmt (Stryker) HoloLens in Germany (Virtual Surgery Intelligence) Microsoft Health  Website • Twitter  Link to Episode 96 with Molly McCarthy The Venue: This conversation was recorded at DOCSF in January 2020, the weekend before #JPM Week in San Francisco. DOCSF is all about the intersection of digital health and musculoskeletal care. This year, the sessions featured leaders from Microsoft, Google, Mozilla, Amazon and many other amazing organizations, and Dan Kendall interviewed some of the speakers following their sessions on the stage. This special series of episodes features some of the interviews recorded at this annual event. To hear all the sessions on the DOCSF podcast, be sure to subscribe to the DOCSF Podcast here or visit Health Podcast Network. Get more content: Browse episodes on Digital Health Today  Browse episodes on the DOCSF Podcast Follow Digital Health Today on Twitter, Linkedin, Facebook and Instagram Follow the Health Podcast Network on Linkedin, Twitter, Facebook and Instagram   Digital Health Today is made possible by the support of our sponsors. Thank you to Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics Learn more about your ad choices. Visit megaphone.fm/adchoices

Kellogg’s – SVP of Global R&D and self-described Willy Wonka of Kellogg’s, Nigel Hughes is on a journey to understand […]

Such an amazing news that Atlassian is expanding their presence in India. Good for everyone and definitely great news for professionals working in this field.

In this second installment of the James Beard Foundation Food Summit 2017: Consuming Power, listen as author Mark Schatzker moderates a discussion on taste and industry titled Leading with Taste with chef and author Dan Barber (The Third Plate) and Mary Wagner of MK Wagner & Associates. Then journalist Tamar Haspel moderates a panel titled Money Where Your Mouth Is: Companies Adjusting to Changing Consumer Beliefs, Behaviors, and Tastes, with speakers Josh Anthony (Campbell’s and Global Nutrition), Alexia Howard (AB Berstein), Mehmood Khan (PepsiCo’s Global R&D), and Jason Lepes (Fresh Direct). Hear them discuss the ethics and psychological complexities of modern food consumption, the intersections of purchasing power and bodily health, and how what we buy impacts the current state of the planet and our Earth’s farmers. Finally, Kris Moon moderates Levers for Change: Grass Roots Advocacy and Action as he chats with the co-directors of the Food Chain Workers Alliance Joann Lo and Jose Oliva, where they examine how the current political climate in regards to immigration policy will heavily impact our food supply and labor pathways, followed by a speech on the power of litigating for change by Kim Richman (Richman Law Group). Heritage Radio Network on Tour is powered by Simplecast.

Neste episódio histórico do Endörfina conversei com os pais do triathlon brasileiro. Conheça aqui o casal que foi responsável por descobrir o então novíssimo esporte do triathlon (3 anos de existência) em uma conversa durante uma viagem que o casal fez a Honolulu em 1981, para cobrir a Maratona daquela cidade. Felizmente o espírito empreendedor do jornalista carioca José Inácio Werneck e sua esposa, a inglesa Dawn Webb, os fez ter a idéia de trazer o novo esporte para o Rio de Janeiro. Nascia então o triathlon brasileiro! A primeira edição, chamada informalmente de Corrida Alegre, aconteceu em fevereiro de 1982. Por exigência da Escola de Educação Física do Exército, porém, o ciclismo seria a última modalidade desta primeira prova. Dos quase mil inscritos, cerca de 320 pessoas optaram por participar das três modalidades do evento que começou com 500 metros de natação as 6h45 na Urca. Depois os participantes correram 8km pela praia de Botafogo e pedalaram do Urca até o centro da cidade passando pelo aterro. O primeiro a sair da água foi o falecido nadador olímpico (posteriormente foi cantor e ator Global) Rômulo Arantes (patrocinado para este evento pela Caloi!), seguido de perto por Carlos Roberto Dolabella e Marco Ripper (ambos da equipe HASPA). O caráter da prova foi recreativo (daí o nome) e houve mais de uma largada para quem não queria nadar. Uma matéria de jornal da época relata a participação de uma jovem de 10 anos (Alexandra Viana) e a presença da nadadora, também olímpica, Maria Lenk como espectadora. O "pódio" masculino: Dolabella, Ripper e Rômulo. Um ano depois, em 1983, já na ordem tradicional, Werneck organizou o triathlon Café do Brasil, também no Rio de Janeiro, que contou com a participação de estrangeiros convidados e teve a vitória de Roger de Moraes. O resto é história! Aproveitem!

I continue my discussion of operationalizing your compliance program through the risk management process by considering risk-based monitoring. I continue this series based upon interviews with Ben Locwin, Director of Global R&D at BioGen and an operational strategist in pharma and healthcare, to explore risk forecast, risk assessment and risk monitoring for the compliance profession.  Locwin said, “Risk-based monitoring is really about continuous, ongoing monitoring for those things which provide the most potential future risk to you. In other words, instead of a static risk registry that may come in part with forecasting, where you would say, “We’re trying to anticipate these risks.” By using risk-based monitoring to review issues on an ongoing basis, and the models that are behind the risk-based modeling, risk-based monitoring models, they’re continuously refined based on incoming data.”  The problem for many companies is they are siloed in not only their data but also in the systems. Locwin explained that because of the disparity of data systems, “They may not be tracking rigorous, quantified information all the time.” He cited to an example from the pharmaceutical world where a company could well have 50 worldwide sites where a drug product is being tested. Some patients receive a placebo and some patients receive the medication being tested. As data comes in you begin to note patterns in certain patients and groups, which might actually point towards a variety of testing errors by physicians administering the test.  Through the use of risk-based monitoring, you can begin to see things in “almost real-time, time-based trends of real data that you can then jump on and try to make adjustments before things get really wacky.” The implications to the compliance practitioner? Having access to information around sales, the sales process and corporate largess in things from Corporate Social Responsibility (CSR) work to gifts, travel and entertainment to conferences for customers and end users. Through the use of such risked-based monitoring a compliance professional would have the opportunity see trends developing which could allow an intervention for a prescriptive solution which could prevent an issue from becoming a Foreign Corrupt Practices Act (FCPA) violation. Yet Locwin cautioned that compliance professionals should guard against bias. In an article by Locwin, entitled “Be Careful When Appraising Industry Trends”, he stated, “Social media has rapidly accelerated the agility with which the public can change allegiance and direction. It used to be that when information dissemination was slower and more compartmentalized within regions and market segments, that the market resistance to fluctuation was more robust. Now well-placed advertising, social commentary, or public response to corporate missteps can swirl into a maelstrom of market changes within hours that is agnostic to region or market segment.”  In today’s world, the speed at which reputational damage reigns out can overwhelm a corporation’s ability to respond. Here one might consider Wells Fargo and how fast the situation spun out of control for them after its $185MM fine was announced. It is through the use of risk-based monitoring, which allows for this almost real-time input, that a response to a forecasted, assessed or even unassessed risk can be developed. In the compliance world, such tools could be brought to bear when considering not only the expense side of such areas as gifts, travel and entertainment but also sales side data. This could be internal company data on its own salesforce and also information developed from or concerning your third-party sales team.  In Locwin’s primary world of pharmaceutical testing and product development, the need for such real-time information can be more critical. Yet through the development of these techniques as compliance tools, the compliance profession can add value to an organization through the use of risk-based monitoring. With the plethora of data on where and how corruption is likely to occur, coupled with meaningful sales and expense data, the compliance professional should be able to move from detect to prevent to prescriptive compliance solutions to prevent legal violations.  Finally, the beauty of all these techniques is that they are tools that can make companies more efficient and, at the end of the day, more profitable. They also move compliance into the fabric and DNA of an organization or in the terminology of the Department of Justice (DOJ) Evaluation of Corporate Compliance Programs, operationalize compliance. The DOJ has made clear what it expects around the risk management process. You need to develop your response now.  Three Key Takeaways Risk-based monitoring is a follow on from forecasting and risk assessments in the risk management process. Risk based monitoring can provide real-time feedback and input from your operationalized compliance program. Use risk-based monitoring to cut through corporate siloes.  This month’s podcast series is sponsored by Oversight Systems, Inc. Oversight’s automated transaction monitoring solution, Insights On Demand for FCPA, operationalizes your compliance program. For more information, go to OversightSystems.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, I begin a three-podcast series on risk management in compliance with Ben Locwin, Director of Global R&D at BioGen and an operational strategist in pharma and healthcare, to explore risk forecast, risk assessment and risk monitoring for the compliance profession. Today we consider forecasting in the risk management process.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Podängen #6 I det här avsnitett gästas Didrik av Axel, Nathaly och Fanny. Vi pratar om vad global har haft för sig på sistone och vad dom kommer ha för sig i framtiden nu när dom efter höstlovet åker iväg till Sydamerika! Vi pratar också om veckans kulturlunch, där legendariska svenska animatören Per Åhlin gästade på skolan. […]

The Environmental Protection Agency's calendar keeps turning. Auto manufacturers are on a deadline to raise their total mpgs. Most are pushing their engineers to come up with gas-sipping ICEs as well as alternative powertrains like electrics and hybrids. But in addition, they are also turning to lighter weight materials like carbon fiber. Though still extremely expensive, manufacturers and suppliers alike are looking at ways to make the product cheaper so it can go on vehicles of all prices. On Autoline This Week John McElroy welcomes three people from the carbon fiber world. Florian Schattenmann is the Global R and D Director for supplier Dow Chemical, Graham Henkel is the designer of the new Viper from Chrysler's SRT division while James Staargaard is the president of Plasan Carbon Composites.

The Environmental Protection Agency's calendar keeps turning. Auto manufacturers are on a deadline to raise their total mpgs. Most are pushing their engineers to come up with gas-sipping ICEs as well as alternative powertrains like electrics and hybrids. But in addition, they are also turning to lighter weight materials like carbon fiber. Though still extremely expensive, manufacturers and suppliers alike are looking at ways to make the product cheaper so it can go on vehicles of all prices. On Autoline This Week John McElroy welcomes three people from the carbon fiber world. Florian Schattenmann is the Global R and D Director for supplier Dow Chemical, Graham Henkel is the designer of the new Viper from Chrysler's SRT division while James Staargaard is the president of Plasan Carbon Composites.

The Environmental Protection Agency's calendar keeps turning. Auto manufacturers are on a deadline to raise their total mpgs. Most are pushing their engineers to come up with gas-sipping ICEs as well as alternative powertrains like electrics and hybrids. But in addition, they are also turning to lighter weight materials like carbon fiber. Though still extremely expensive, manufacturers and suppliers alike are looking at ways to make the product cheaper so it can go on vehicles of all prices. On Autoline This Week John McElroy welcomes three people from the carbon fiber world. Florian Schattenmann is the Global R and D Director for supplier Dow Chemical, Graham Henkel is the designer of the new Viper from Chrysler's SRT division while James Staargaard is the president of Plasan Carbon Composites.

Professor Anne Mills of the London School of Hygiene and Tropical Medicine explains to Peter Goodwin how health systems development in Thailand has achieved healthcare coverage for all citizens, irrespective of ability to pay. Following her award of the Prince Mahidol Prize for Medicine — and in the light of the work she has done in Asia and Africa — she discusses how the Thai experience could give lessons for developing health systems in low and middle income countries in other parts of the world.